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Background: The Cox maze procedure has shown to be effective in treating atrial
fibrillation. Radiofrequency ablation, with a similar objective, has been used as an
adjunct to conventional cardiac surgery for the treatment of atrial fibrillation in more
than 20 centers in Australia and New Zealand since March 2000. This is a report of
those results.
Methods: One hundred thirty-two patients in 20 centers underwent radiofrequency
ablation as an adjunct to conventional cardiac surgery, with a standardized lesion set
created with a flexible, 7-electrode, temperature-controlled probe (Cobra; EPTech-
nologies, San Jose, Calif). All data were entered into a central registry, with regular
follow-up prompted by the registry cocoordinator. Each radiofrequency scar was
made with standard parameters requiring 2 minutes of tissue coagulation at 80°C to
85°C. Patients undergoing mitral procedures had radiofrequency ablation performed
in the left atrium endocardially. Patients undergoing aortic valve replacement or
coronary artery bypass surgery underwent epicardial radiofrequency ablation of the
left atrium. Epicardial radiofrequency ablation lesions on the right atrium were
common to both groups of patients. Preoperatively, 75% of the patients had chronic
atrial fibrillation, 21% had paroxysmal atrial fibrillation, and 4% had flutter. Sur-
gical procedures performed included mitral valve procedure in 60%, coronary artery
bypass grafting in 14%, aortic valve replacement in 7%, and coronary artery bypass
grafting plus aortic valve replacement in 4%.
Results: There were no major complications related to the use of radiofrequency
ablation. There were no soft tissue or cardiac perforations. Ten patients were
defibrillated into sinus rhythm within 3 months postoperatively. The freedom from
atrial fibrillation was 84% at 3 months, 90% at 6 months, and 100% at 12 months.
All patients at 12 and 18 months’ follow-up were in sinus rhythm. There were no
thromboembolic complications.
Conclusions: Surgical radiofrequency ablation can be performed safely as an ad-
junct to conventional cardiac surgery. A standardized lesion set created by using
similar temperature settings can be adopted in multiple centers and might be
effective in treating atrial fibrillation. Data collection through a central registry has
helped in monitoring the effectiveness of this new technique in a scattered popu-
lation.
Atrial fibrillation (AF) is the most common of all sustained arrhyth-mias.1 It occurs in 6% of the population older than 65 years ofage2 and is the most frequent cause of strokes in the elderly.3,4The role of medical therapy, whether by attempting to restoresinus rhythm5 or with anticoagulation,6 is reasonably well estab-lished. However, there is no cocoordinated surgical strategy to
deal with this common problem, despite the pioneering development of a specific
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procedure by Dr James Cox for this condition (ie, the maze
procedure).7 An elegant and innovative approach to AF, this
technique and its variations require multiple atrial incisions,
which need to be sutured.8 These sutured incisions are
full-thickness scars that act as lines of electrical block.
Despite the development of the maze procedure in the late
1980s and its propagation in the 1990s, most cardiac sur-
geons have hesitated at using this technique. In part, this
might be due to the perceived increased complexity and risk
associated with multiple incisions in a posterior structure,
such as the left atrium.9-11 Indeed, surgeons who have
vigorously adopted the maze procedure have been those
renowned for their skill, working in reputable centers of
high volume, such as the Cleveland Clinic12 and the Mayo
Clinic.13 Their results have been very good. Despite reason-
ably good results with the modified maze procedure per-
formed by Dr David Johnson in Sydney in the early 1990s,
the procedure was not adopted by any of the other centers in
Australia or New Zealand.
We chose to replace the cut-and-sew approach with
radiofrequency ablation (RFA) to create transmural lines of
electrical block on the basis of animal work performed at
our laboratory.14 Our early clinical experience15 helped
pave the way for the adoption of RFA as an adjunct to
conventional cardiac surgery in many centers across Aus-
tralia and New Zealand. This is a preliminary report on this
multicenter experience.
Methods
Surgical Technique
Radiofrequency lesions were created by using the flexible, 7-elec-
trode, temperature-controlled Cobra probe (EP Technologies, Bos-
ton Scientific Corp, San Jose, Calif). Lesion creation parameters
were set at 80°C to 85°C for 2 minutes to achieve transmural scars.
The lesion set combined elements of the maze procedure as de-
scribed by Cox and colleagues,16 the radial procedure as described
by Nitta and associates,17 and the bilateral isolation of pulmonary
veins as described by Melo and coworkers.18
Figure 1 shows the schematic diagram of the lesion set chosen
by our group (4a being the endocardial lesions used in the mitral
procedures, 1b being the epicardial lesions on the left atrium used
in aortic valve/coronary artery bypass grafting [CABG] proce-
dures, and 1c being epicardial right atrial lesions used in both). The
numbered lines are a suggested sequence of lesions meant to help
with training surgeons unfamiliar with RFA of the atria, the maze
procedure, or both. The steps of the procedure are described in the
diagram. The left atrial appendage was oversewn in a linear
fashion from within, and this plicating suture helped gather up
redundant atrial tissue in this region going up to the atrial roof.
Pulling up on the uncut ends of the suture also helped display the
left-sided pulmonary vein orifices.
Steps in Adoption of the Technique
Patients with established AF undergoing conventional cardiac sur-
gical procedures were considered. Patient enrollment in this expe-
rience was based on the surgeon’s discretion. All patients provided
informed written consent. Only 3 of the participating centers
required that these procedures be ratified by an institutional review
board. With the advent of strict privacy laws in Australia in
mid-2001, it was mandatory for all patients to consent separately
for inclusion of their names and records in a central database.
In the first half of our experience, all patients had AF docu-
mented on a preoperative 24-hour Holter electrocardiographic
monitor, before being offered RFA. Initially, the procedure was
performed only in association with mitral valve surgery. The RFA
procedure was also used in such a way that there was no significant
alteration of the surgeon’s current approach and technique.
Safety precautions were prescribed and consisted of the fol-
lowing:
1. Adequate placement of adhesive grounding pads was used to
ensure proper creation of radiofrequency lesions.
2. Withdrawal of the transesophageal echocardiographic probe
from the mid-esophagus and turning off of the echocardio-
graphic machine were used to minimize the risk of esopha-
geal injury. The lesion set in the posterior left atrium also
avoided the most dependant portion of the left atrium, which
was likely to be in contact with the esophagus.
3. If the probe shut off, the system was shut down and restarted.
This was to avoid overheating the tissue.
4. The probe was always placed under direct vision or by
means of palpation, with care taken to ensure tissue contact.
This was done to avoid collateral damage in surrounding
structures and to ensure accurate lesion creation.
5. Lesions were created close to the circumflex artery within
the left atrium with infusion of cardioplegia. Lesions close to
the right coronary artery on the right atrioventricular groove
were created with the heart beating. This was primarily to
avoid injury to the relevant coronary arteries. In addition, if
the right coronary artery was large and mobile, this was
dissected gently and pushed anteriorly out of the way of the
probe.
6. Surgeons were also asked to watch the change in atrial tissue
color with the application of the radiofrequency energy.
Epicardial Applications
As confidence in the technique grew and evidence of the transmu-
ral nature of the epicardial lesions was established, surgical RFA
was extended to patients undergoing aortic valve procedures and
coronary artery surgery. Epicardial lesions were created in these
patients. All procedures were performed with aid of cardiopulmo-
nary bypass. In the epicardial setting, all lesions were created
during cardiopulmonary bypass. In the early part of the experience,
the posterior left atrial lesions were created on an arrested heart to
facilitate access. Later in the experience, the trend was to perform
these lesions on a decompressed heart during CPB, either with the
aid of a left ventricular vent or bicaval cannulation. The fat pad
around the pulmonary veins was dissected until the underlying
muscle was seen. Unfortunately, this meant that the epicardial
lesions in the posterior left atrium did not reach the mitral valve
annulus. The lesion to the tricuspid valve annulus was performed
low down on the anterior aspect of the right atrioventricular
groove. If required, the right coronary artery was dissected free
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Figure 1. A, Left endocardial lesion set with mitral procedures: step 1, closure of the left atrial appendage from within;
step 2, linear lesion along the roof of the left atrium; step 3, encircling lesion around right-sided pulmonary veins; step
4, encircling lesion around left-sided pulmonary veins with connecting lesion to mitral valve annulus; step 5, connecting
lesion to mitral annulus from lower right pulmonary vein orifice. B, Left atrial epicardial lesion set with aortic valve or
CABG: step 1, linear lesion along the roof of the left atrium; step 2, ligation of the base of the left atrial appendage from
the outside; step 3, encircling lesions around left-sided pulmonary veins; step 4, encircling lesions around right-sided
pulmonary veins with a connecting lesion toward the atrioventricular groove. C, Common epicardial lesion on the right
atrium: step 6, linear epicardial lesion from behind the sinoatrial node approximately along the direction of the crista
terminalis, curving up to the atrioventricular groove; step 7, connecting lesion from the inferior vena caval orifice to the
right atrioventricular groove low on the body of the right atrium.
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and pushed anteriorly to allow the probe to sit at the atrioventric-
ular groove.
There were no stand-alone procedures performed for AF alone.
When each new surgeon and center was trained in the use of the
probe, care was taken to ensure uniformity of the lesion sets and
parameters used to create them.
Details of all patients who had the procedure performed with
the Cobra probe were entered into a centrally maintained registry.
The purchase price of each probe also included a fee to help with
the set-up and running costs of the registry. A protocol of clinical,
echocardiographic, and electrocardiographic follow-up was sug-
gested to each of the participating surgeons.
Study Population
All patients underwent a definite cardiac surgical procedure, which
was the primary indication for surgical intervention. Patients were
referred for surgical intervention by their cardiologists, and the
decision to proceed was taken in consultation with the cardiac
surgeon. Although the addition of RFA to the procedure did
increase operative time, it was perceived by most participating
surgeons as relatively innocuous. If there was a history of AF,
random 24-hour Holter monitoring was performed, and the patient
was offered RFA. All surgical RFA procedures were performed as
an adjunct to conventional cardiac surgical procedures with the aid
of cardiopulmonary bypass. All patients who underwent RFA were
included in this study, irrespective of the risk and urgency of the
procedure.
One hundred thirty-two patients underwent surgical RFA pro-
cedures between March 2000 and March 2002 at 20 hospitals
across Australia and New Zealand. Table 1 outlines the patient
demographics of this study. The mean age of these patients was 66
years (range, 21-86 years). Preoperatively, 75% of the patients had
chronic AF, 21% had paroxysmal AF, and 4% had a combination
of flutter and fibrillation. The mean duration of preoperative
rhythm disturbance was 36 months, ranging from 1 to 120 months.
Although the recommendation was to apply this procedure in
patients with long-standing AF (ie, duration 6 months), the
multicenter nature of this experience placed the onus of patient
enrollment on the surgeon’s discretion and judgment. Almost all of
the patients had clinically documented AF for more than 6 months.
This report includes all the patients recruited, regardless of indi-
cation, and is a true warts and all account.
No patient’s record was left out if the selection of the procedure
was inappropriate.
The primary surgical procedures were mitral valve procedures
in 62 patients. Mitral valve procedures and CABG were performed
in 10 patients. Combined aortic and mitral procedures were per-
formed in 7 patients. CABG was performed in 19 patients. Aortic
valve procedures were performed in 9 patients. In total, endocar-
dial RFA on the left atrium was performed in 92 patients, and
epicardial RFA on the left atrium was applied in 40 patients.
Pharmacologic Protocol
Postoperatively, patients were not started on any specific regimen
of anticoagulation. However, as the multicenter experience began,
patients were encouraged to take low-dose amiodarone (200 mg/d)
for 6 months unless specifically contraindicated.
Statistical Analysis
Statistical analysis was conducted with SAS version 5.0 software
(SAS Institute, Inc, Cary, NC). Continuous data were expressed as
means SD. The Student t test and 2 test were used for statistical
analysis.
Results
Operative Results
There were no intraoperative atrial perforations or periop-
erative tissue perforations in this series. All patients were
weaned off cardiopulmonary bypass in a regular sinus or
paced rhythm. Initially with the mitral procedures, surgeons
on their learning curve took about 20 minutes of extra
crossclamp time to create the lesions. With practice, this
could be reduced to approximately 12 to 14 minutes.
There were 9 perioperative deaths. None were related to
the use of RFA. One was due to remote aortic dissection in
a patient who had replacement of the ascending aorta.
Another was due to severe liver dysfunction caused by
coagulopathy and tamponade in an elderly woman with a
very fragile and calcified aortic root that leaked after valve
replacement. The third was a decompensated patient on a
balloon pump with uncontrolled AF, who had a very poor
ventricle caused by large infarcts, severe aortic regurgita-
tion, and uncontrolled tachycardia. He arrested soon after
anesthetic induction and was salvaged. RFA was used in
this patient to achieve good rate control and in the hope of
avoiding amiodarone. Despite a relatively stable postoper-
ative course, there was no recovery of ventricular function
on day 5, and prolonged mechanical support was not an
option. In retrospect, this patient should have had another
TABLE 1. Patient demographics
Characteristic No (%)
No. of patients 132
Age, y 66  12 [range, 21–86]
Sex, M/F 91/41 (69/31)
Preoperative rhythm
Chronic AF 99 (75)
Paroxysmal AF 28 (21)
Atrial flutter 5 (4)
Surgical procedure
Endocardial RFA on LA 92 (70)
Isolated mitral valve 62 (47)
Mitral valve  CABG 10 (8)
AVR  MV procedure 7 (5)
CABG  ASD closure 1 (0.7)
Redo Ebstein repair 1
Other 11 (8.3)
Epicardial RFA on LA 40 (30)
CABG 19 (14)
AVR 9 (7)
AVR  CABG 5 (4)
Other 7 (5.3)
LA, Left atrium; AVR, aortic valve replacement; ASD, atrial septal defect. All
numbers are actual figures and figures in parentheses are percentages.
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means of rate control. However, the radiofrequency lesions
were created with the heart beating on CPB, with no addi-
tion to the crossclamp time. A fourth patient died on the
eighth postoperative day at home from a hemorrhaging
duodenal ulcer. There was one death caused by cardiogenic
shock as a result of a large infarct complicating a delayed
low-output syndrome on day 6 after the operation. In this
instance the infarct was septal and related to a very diseased
left anterior descending artery. It is unlikely that radiofre-
quency energy was applied close to the left anterior de-
scending artery. There was one death caused by periopera-
tive gut ischemia in a patient who underwent successful
mitral valve repair and CABG. One patient with a very poor
ventricle who had mitral valve repair for severe regurgita-
tion died of a postoperative low systemic vascular resistance
syndrome resistant to norepinephrine and vasopressin. De-
tails on 2 other deaths were sketchy but related to postop-
erative low-output states in elderly patients.
We attempted to study a control group of patients with
preexisting AF who had cardiac surgery but did not have
any antiarrhythmic procedures. However, this proved ex-
tremely difficult in a multicenter setting and was aban-
doned.
Although the recommendation was that patients continue
to receive amiodarone for 6 months, there was variable
compliance by treating surgeons and patients
Follow-up
From a total of 132 patients undergoing the procedure,
follow-up was attempted in the 123 survivors. Twelve pa-
tients had undergone operations within 3 months of this
publication and hence were not available for out-of-hospital
follow-up. Mean follow-up was 6.4 months (range, 3-24
months), with complete clinical review in 110 patients.
Eighty-seven patients underwent the follow-up evaluation
for 3 months, 50 for more than 6 months, and 15 for more
than 12 months. Follow-up data at 6 months were not yet
available in another 12 patients. Figure 2 is a representation
of rhythm preoperatively and postoperatively in the patients
enrolled in the study. The sinus recovery rate was 84% at 3
months (72 of 87), 90% at 6 months (45 of 50), and 100%
at 12 months. Ten patients required cardioversion postop-
eratively. Five of them had cardioversion within 2 weeks,
and 5 had cardioversion within 3 months. Recovery of sinus
rhythm occurred in 9 (90%) of these patients. In the follow-up
period, return to sinus rhythm was documented by means of
electrocardiography and Holter monitoring, which was usually
performed between 3 and 6 months postoperatively. No stress
tests were performed to examine sinus node function.
Dual-chamber pacemakers were implanted in 4 patients.
One of them underwent a redo repair of an Ebstein anomaly
with a modified Danielson approach in which there was
significant fibrous reaction around the triangle of Koch.
Another had idiopathic viral cardiomyopathy 3 months after
the operation and required mechanical ventricular support
for 7 days. She had sinus bradycardia after that illness, and
a rate-responsive pacemaker was implanted in an effort to
improve her exercise tolerance. A third patient had a trans-
septal approach for a mitral valve repair, and a pacemaker
was implanted on day 4 for persistent atrioventricular block.
The fourth patient with coronary artery disease had implan-
tation of a pacemaker 6 months postoperatively for sick
sinus syndrome. Table 2 looks at the recovery of sinus
rhythm on the basis of the type of preoperative rhythm (ie,
chronic vs episodic AF). Although there were fewer patients
with episodic AF, their sinus recovery rates tended to be
higher. Table 3 examines the effect of the type of left atrial
Figure 2. Rhythm profile preoperatively and postoperatively (n  132 patients). PPM, Permanent pacemaker.
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lesion, whether endocardial or epicardial, on the recovery of
sinus rhythm. The type of lesion did not cause a significant
difference in the recovery of sinus rhythm.
“Atrial contractility” is a term that is used often but can
be difficult to quantify. Spectral velocities across the mitral
valve have been used to calculate E- and A-wave values.
Table 4 shows the spectral mitral velocities and the diam-
eters of the left atria in the patients followed up at a mean
of 3 months. These calculations might not have much value
in the presence of a mitral valve prosthesis or a repaired
mitral valve. There were no thromboembolic complications
recorded in these patients.
Patients were not anticoagulated unless required, such as
in the case of a mechanical valve implant. Thirty-two (26%)
patients were taking oral warfarin for the implantation of a
mechanical valve. Eight patients had implantation of a bi-
ologic prosthetic valve that obviated the use of warfarin. All
patients not receiving warfarin were taking low-dose aspi-
rin. Careful review of the database suggested that the par-
ticipating surgeons had varying attitudes toward anticoagu-
lation for postoperative AF, and the use of anticoagulation
in this setting was not uniformly recorded or reported.
Antiarrhythmic drugs were often only used if the patients
were in recurrent AF. Similarly, interval episodes of early
fibrillation after discharge from the hospital could not be
tracked unless they were clinically significant or the patients
reported it on their own. Routine follow-up visits were orga-
nized at 6 weeks and 3, 6, and 12 months postoperatively.
There were 6 readmissions with recurrent AF, sinus
bradycardia, or both in the first 3 months postoperatively.
There was one late death in a patient who had infective
endocarditis complicated by liver failure 8 months postop-
eratively.
Discussion
The maze procedure remains the gold standard in terms of
surgical therapy for AF, with excellent results reported by
Cox and colleagues.19 A few other selected groups have
replicated similar results.20,21 However, most of these series
of patients have been performed only for AF. In the setting
of mitral valve surgery or other cardiac surgical procedures,
many surgeons are reluctant to use the maze procedure
because of increases in crossclamp time and operative
risks.9 Although many publications about the maze proce-
dure talk about its efficacy in controlling AF, there is little
mention in the surgical literature of the morbidity associated
with the procedure. Indeed, in many instances anecdotal
experiences are recounted informally by surgeons and sur-
gical trainees about perioperative bleeding and longer pro-
cedure times associated with the procedure. This might be
why the maze procedure has not enjoyed more widespread
surgical acceptance.
In the race to create scars of electrical block, a range of
different energy sources is being tested. RFA, which uses a
form of alternating current, causing tissue coagulation by
means of resistive heating, has been adapted from the elec-
trophysiologist’s repertoire.22 Cardiac electrophysiologists
work from the endocardial aspect, causing focal ablation of
ectopic foci of atrial tissue, especially in the pulmonary vein
orifices.23 These techniques are limited by swirling blood
that reduces energy delivery and poor geographic localiza-
tion, relying on intracardiac echocardiography. To reduce
the risk of thromboembolism and to allow for maximal focal
delivery of radiofrequency energy, most electrophysiolo-
gists rely on temperature settings at a maximum of 70°C for
less than 60 seconds. Their goal also is to cause focal
ablation endocardially. This approach cannot be used for the
treatment of AF.24
Surgical goals in the treatment of AF are different. If the
principles of the maze procedure are to be emulated or
replicated without cutting and sewing, transmural scars that
act as lines of electrical block are required. Surgeons per-
forming a combined surgical procedure have little time to
measure electrograms or study maps intraoperatively to
ensure transmurality.25 Patwardhan and associates26 used
radiofrequency microbipolar coagulation in an early attempt
TABLE 2. Effect of preoperative rhythm on recovery of
sinus rhythm
Preoperative rhythm
Follow-up rhythm
at 3 mo
Follow-up rhythm
at 6 mo
Chronic AF 53/64 (83%) 30/37 (81%)
Paroxysmal AF 18/21 (86%) 12/12 (100%)
TABLE 3. Return to sinus rhythm on the basis of type of left
atrial lesion
Type of left atrial
lesions Sinus rhythm at 3 mo Sinus rhythm at 6 mo
Endocardial 54/66 (82%) 35/39 (90%)
Epicardial 18/21 (86%) 10/11 (91%)
TABLE 4. Echocardiographic features
Endocardial RFA Epicardial RFA
Preoperative
Left atrial diameter (mm) 54 3 45 4
Postoperative
Left atrial diameter (mm) 49 7 48 1
Peak E velocity (m/s) 1.88 0.66* 0.47 0.3*
Peak A velocity (m/s) 0.32 0.02 0.39 0.12
Endocardial, Endocardial RFA on left atrium; Epicardial, epicardial RFA on
left atrium; Peak E velocity, peak transmitral early diastolic filling velocity;
Peak A velocity, peak transmitral atrial filling velocity.
*P  .05 denotes the difference between endocardial and epicardial
groups.
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to perform a maze modification. While pioneering RFA for
AF, Melo and coworkers27 used parameters set by the
cardiac electrophysiologists, causing lesions that might not
have been quite transmural. That might explain the medio-
cre results obtained in his early reports. Numerous authors
have described the creation of transmural lesions with sur-
gical probes used for RFA.28,29 The Cobra probe specifi-
cally has been shown to create transmural lesions when used
appropriately in animals.30
Our experience with the Cobra probe and its predecessor
was in the animal laboratory. Quite by accident, we discov-
ered that transmural lesions could be achieved consistently
only by using a temperature setting of 80°C to 85°C for 120
seconds. We did not publish this information separately, but
part of it is lost in the detail of some experimental work on
a model of atrial flutter in sheep.12 This feedback, however,
does not seem to have been relayed to other users of this
technology. When the Australasian multicenter study got
underway, rigorous attempts were made to ensure that the
probe was used accurately, appropriately, and safely, with
fixed parameters. Because the goal is creation of transmural
scars created by coagulation of atrial tissue, it might be time
to replace the term “RFA” with “radiofrequency coagula-
tion” when used surgically.
In this context, while transmural scars are being created,
the potential for collateral damage, such as esophageal
injury, exists, as reported by Gillinov and colleagues31 and
Mohr and associates.32 The lack of major tissue perforations
in this multicenter experience, which included the learning
curve, might be partly due to the rigorous adherence of the
various surgeons to the protocol. The reinforcement by
representatives of the probe manufacturers also helped
maintain safety standards.
In a very timely editorial, Cox33 reminded us that there
were too many variables, ranging from lesion patterns to the
kind of energy types and settings, in the adaptation of a
variety of energy sources, including RFA, in the race to
replace the maze procedure. It has been difficult to delineate
the benefits of one technique over another. In addition, the
majority of the reports seem to emanate from one center that
specializes in the application of that particular technique.
Table 5 compares patient profiles, mortalities, and numbers
of patients undergoing concomitant procedures in the recent
literature, citing large, single-center maze experiences and
one single-center radiofrequency experience for compari-
son.
Although the maze procedure has not been proposed for
the problem of flutter, at least one report mentions its use for
the treatment of atrial flutter.34
The longer-term follow-up from the Australasian registry
is important in this respect because it will focus on the
results of a specific pattern of lesions that have been created
by fairly uniform settings of radiofrequency energy in mul-
tiple centers. The early results with this technique across
Australia and New Zealand have been safe and satisfactory.
Similar to the experience in Berlin,35 our follow-up showed
a steady improvement over time in recovery of sinus
rhythm. This also suggests that early susceptibility to AF
after cardiac surgery is not significantly changed by RFA.
Interestingly, the kind of left atrial lesions did not signifi-
cantly alter the recovery of sinus rhythm. Patients with
preoperative paroxysmal AF showed trends toward better
recovery of sinus rhythm, and this might again be a reflec-
tion of smaller atria with focal triggers.
“Atrial transport function” is a term used freely in most
publications about the maze procedure and its modifica-
tions. There is a great emphasis on transmitral Doppler
velocities across the mitral valve.36,37 However, as most
echocardiocardiologists point out, these velocities and ratios
are imprecise markers of atrial function and might be quite
fallacious in the setting of prosthetic mitral valves or mitral
valve repairs.38 The left atrial appendage is overseen or
obliterated, and the emptying velocity of the appendage,
which is often used to measure atrial transport, cannot be
used. Some echocardiologists have suggested using atrial
diastolic and systolic volumes. However, echocardiographic
assessment of these volumes can be variable and very
operator dependant. These measurements would be more
accurate when assessed by means of magnetic resonance
imaging. These are areas that need more discussion and
investigation. The difference in E/A ratios in the endocar-
dial versus epicardial group might reflect the difference in
atrial size in the 2 groups. The other important feature in the
follow-up of the Australasian registry patients was the lack
TABLE 5. Patient characteristics in published series of maze procedures
Author and Center No. of patients
Concomitant surgery
performed Age (y) Mortality Sinus rhythm
Cox39 299 83 (28%) ? 6% 95%
Doty (LDS, Utah)40 99 78 (78%) 62.9 10 0 87%
Schaff (Mayo Clinic)41 173 114 (66%) 60 1.2% 80%
McCarthy (Cleveland Clinic)42 83 60 (72%) 59 10 1% 90.4%
Sie (Maastricht)43* 122 100% 69 10 4.1% 77%
Australasian multicenter study* 132 100% 67 11 6.8% 90%
*RFA experience, as opposed to the cut-and-sew maze procedure from the other centers.
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of any significant thromboembolic complications, which
could be a clinical surrogate for atrial transport function.
Finally, maintaining a registry of this size requires a
significant financial commitment and a good registry co-
coordinator in addition to regular surgical audits and the
cooperation of surgeons. It is our sincere hope that this
registry can be continued in the present form at least for the
next few years to establish the long-term results of surgical
RFA/radiofrequency coagulation in the treatment of AF.
We acknowledge the tireless efforts of Meg Storer and all the
physicians’ secretaries who facilitated follow-up through the reg-
istry and Deirn Geard who helped fund and run the registry. The
surgeons who contributed to this series of patients have been
tremendously cooperative, and we thank them profusely. They
include Drs Aubrey Almeida, Anand Dixit, Ben Bidstrup, Richard
Chard, Michael Gardner, Hugh Wolfenden, Harsh Singh, Tevor
Fayers, Ian Gilfillan, Jacob Goldstein, Terrence Mau, George
Matalanis, Mark Murton, Michael Gardner, Ian Nicholson, Alex-
ander Rosalion, Robert Tam, Peter Tesar, Gil Shardey, Siven
Seevanayagam, and Julian Smith. It is our hope that in the future,
publications from this group will be published in the format of a
multicenter cooperative study.
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Discussion
Dr J. Cox (Washington, DC). Dr Raman and his colleagues at
the other 19 hospitals in this multicenter study are to be com-
mended for achieving these rather striking results, especially the
100% cure rate of AF at 12 and 18 months. When I first read these
results several weeks ago, I had difficulty believing them. How-
ever, on closer inspection, I think it is clear that the explanation for
these remarkable results resides in the design criteria of the mul-
ticenter study.
As Dr Raman pointed out, the 2 principles to which all the
participants adhered in this study were that the pattern of lesions
would correspond as closely as possible to those of either the maze
or radial procedures, both of which are proved procedures, and that
every effort would be made to be certain that every portion of
every lesion was transmural.
By adhering to these 2 fundamental principles, the results could
have been predicted, I think, because every previous study that has
taken this approach has resulted in essentially the same results.
This strongly implies, though, that as long as the lesion pattern is
correct and the lesions are transmural, the particular method for
creating those lesions is immaterial to the outcome. In other words,
any energy source or technique that is capable of creating the
correct lesion pattern and is uniformly transmural will result in a
cure of AF in essentially all patients.
I have 2 questions for Dr Raman. Why do you think the results
improved with time, because that has not been the experience in
most other studies? Second, you note that there was no AF on
long-term follow-up, but did those patients ever experience epi-
sodes of atrial flutter?
I congratulate Dr Raman and his associates on a well-designed
and important study.
Dr Raman. Thank you very much, Dr Cox. It is a privilege to
actually have you discuss this paper because you served as an
inspiration for us to actually set up this protocol. I will answer the
second question first. In terms of flutter, we had one patient who
had one episode of flutter late, and it resolved spontaneously. This
was asymptomatic flutter, and fortunately, the patient was actually
reviewed at that time by his cardiologist and local doctor. On
subsequent Holter monitoring, he was found to be in sinus rhythm,
and therefore he did not actually need further medications or
specific intervention. A few years ago this man ran marathons. He
was in his 70s, and he went back to running up hills. He said he
used to experience tachycardia or felt palpitations coming on when
he ran up a hill, but he did not have this experience postopera-
tively, and I think this was a chance finding that he actually had
flutter, which was relatively slow.
The first question concerns the improvement in AF over time.
I think almost definitely that this procedure does nothing to reduce
the propensity toward early postoperative AF. We all know that
postoperative AF in patients undergoing any cardiac surgical pro-
cedure is about 30%, and despite all the different manipulations,
such as magnesium infusions and -blockade, this still seems a
bugbear. We did not see a difference. Early in the experience, we
were very enthusiastic, and some of the surgeons applied these
procedures in all kinds of patients. I think they have actually been
a lot more selective later on. As our experience grew, we have also
been more aggressive in using cardioversion early on, which might
account for the improvement in the recovery of sinus rhythm. The
other interesting thing, and this is an observation that we have
seen, is that patients who have been followed up for 3 months who
seem to be in fibrillation and then at the 6-month mark they have
reverted to sinus rhythm. I know that this is anecdotal, but I have
at least 3 patients with that, and other people have had similar
experiences. I cannot explain it, but I think they seem to stabilize
electrically with the passage of time.
Dr Joao Melo (Lisbon, Portugal). Congratulations on a beau-
tiful paper. I am happy to see those results, which are much better
than most reported results, including ours. But to understand
whether we are comparing the same type of patients, I noticed that
25% of your patients were not in chronic AF. Therefore, it is
important to know how many of your patients with mitral valve
disease were part of this group of patients. My first question is to
know whether this a selected population. My second question
regards the issue of pacemakers because it is also very striking that
you did your lines on the Cox maze concept and you are reporting
no need for postoperative pacemakers. Can you elaborate on the
reason for that finding?
Dr Raman. As I said, this is a reporting of what we have seen
with this probe, and I cannot speak for specific indications in other
centers, but all patients that had documented AF and came up
initially for mitral valve surgery and later on for coronary artery
surgery or early valve replacement surgery were enrolled, and as
they got more familiar with the technique, they started getting
more confident with it. I cannot tell you with the AF how many of
them had mitral valve disease, but we will look at that carefully.
Dr Ralph Damiano (St Louis, Mo). I would like to echo both
Dr Cox’s and Dr Melo’s congratulations on a beautiful study. One
of the objectives of the maze procedure, or any type of surgery for
AF, is to allow patients to discontinue antiarrhythmic drugs, which
have a high incidence of side effects. I noticed you did not mention
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